Prostrate and Bladder- IHC MCQs Welcome to your Prostrate and Bladder- IHC MCQs 1. Which of the following immunohistochemical marker profile favours nephrogenic adenoma over prostrate carcinoma? A. NKX3.1, PSA(P), PSMA, Prostein, ERG- positive, PAX 8 - positive, AMACR- positive B. NKX3.1, PSA(P), PSMA, Prostein, ERG- negative, PAX 8 - positive, AMACR- positive C. NKX3.1, PSA(P), PSMA, Prostein, ERG- positive, PAX 8 - negative, AMACR- positive D. None of the above 2. Which of the following variants of bladder carcinoma has the same IHC profile as nepheogenic adenoma? A. Clear cell adenocarcinoma B. Sarcomatoid C. Squamous D. Urothelial bladder carcinoma 3. Which of the following IHC markers are useful to differentiate normal urothelium and urothelial carcinoma in situ? A. P53 B. CK 20 C. CD 44 D. All of the above Time is Up! Time's up Share this:FacebookTelegramWhatsAppMoreLinkedInTwitterLike this:Like Loading...